MOH — authorised 27 August 2018
- Marketing authorisation holder: TETRAPHASE PHARMS
- Status: likely_approved
MOH authorised Xerava on 27 August 2018
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 27 August 2018.
TETRAPHASE PHARMS holds the UAE marketing authorisation.